FMTVDM Study Proposal: WID2H - Breast Trial. (Weight, Inflammation, Diet v Drug, Heart disease) - Breast Trial
<p>As we enter this new decade, medicine is presented with the daunting task of resolving incongruities in our existing data and the ever-increasing incidence of obesity, Coronary Artery Disease (CAD) and cancer - including but not limited to breast cancer. The consequence of our failure to qu...
Enregistré dans:
Auteurs principaux: | , , |
---|---|
Format: | Livre |
Publié: |
Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications,
2020-04-21.
|
Sujets: | |
Accès en ligne: | Connect to this object online. |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | peertech__10_17352_2455-2976_000116 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Richard M Fleming |e author |
700 | 1 | 0 | |a Matthew R Fleming |e author |
700 | 1 | 0 | |a William C Dooley |e author |
245 | 0 | 0 | |a FMTVDM Study Proposal: WID2H - Breast Trial. (Weight, Inflammation, Diet v Drug, Heart disease) - Breast Trial |
260 | |b Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications, |c 2020-04-21. | ||
520 | |a <p>As we enter this new decade, medicine is presented with the daunting task of resolving incongruities in our existing data and the ever-increasing incidence of obesity, Coronary Artery Disease (CAD) and cancer - including but not limited to breast cancer. The consequence of our failure to quantitatively measure the impact of diets and drugs at the tissue level where the actual CAD and cancer are occurring has limited our ability to better define the dietary, lifestyle and medication changes required to limit and potentially reverse these inflammatory diseases. </p> | ||
540 | |a Copyright © Richard M Fleming et al. | ||
546 | |a en | ||
655 | 7 | |a Research Article |2 local | |
856 | 4 | 1 | |u https://doi.org/10.17352/2455-2976.000116 |z Connect to this object online. |